Association of Serum Ferritin Levels with Microalbuminuria, Glycemic Control and Dyslipidemia.

Abstract

As diabetes is on the rise worldwide, early screening and detection of its complications is crucial. The first clinical sign of renal dysfunction in diabetes is microalbuminuria. Ferritin may have a possible role in the development and prediction of microalbuminuria and other complications of diabetes by 3 possible mechanisms- 1) it is a marker of elevated body iron stores. 2) acts as acute-phase reactant and elevation reflects inflammation 3) Delayed clearance of glycosylated ferritin in patients with diabetes causes raised ferritin levels. In this premise, we studied the association between serum ferritin levels and microalbuminuria, glycemic control and dyslipidemia in type 2 diabetic patients.

MATERIAL:

A cross-sectional study was carried out at a tertiary hospital in northern India involving 152 patients of type 2 diabetes mellitus. Anthropometric measurements (weight, height), sample collection for basic laboratory parameters including complete blood count, kidney function tests, liver function tests, HbA1c, lipid profile, serum iron and ferritin levels, urinary albumin- creatinine ratio was done. A fundus examination was performed. Results were analyzed using descriptive statistics and making comparisons among various groups. Categorical data were summarized as proportions or percentages while discrete as mean. Chi-square test was used for testing associations.

OBSERVATION:

Mean serum ferritin levels were significantly higher in patients having microalbuminuria as against patients having normal urinary albumin- creatinine ratio (539 vs 292, p-value- 0.04). Patients having poor glycemic control (HbA1c > 7) had higher ferritin levels (p-value- 0.024). There was a near-significant association (p-value-0.06) between serum ferritin and triglyceride levels. More cases with raised serum ferritin had higher triglyceride levels. Patients having microalbuminuria had a higher prevalence of diabetic retinopathy (p-value- 0.003) and higher triglyceride levels (p-value- 0.041).

CONCLUSION:

Ferritin can act as a marker of diabetic nephropathy, poor glycemic control and dyslipidemia in type 2 diabetic patients. Our study, therefore, indicates that programs to prevent complications of diabetes would be more effective by placing greater emphasis on patients having higher ferritin levels.

• Authors: K Dubey, K Usman, S C Chaudhary, K K Sawlani, S K Verma, W Ali
• Journal: The Journal of the Association of Physicians of India (J Assoc Physicians India) Vol. 70 Issue 4 Pg. 11-12 (Apr 2022) ISSN: 0004-5772 [Print] India
• PMID: 35443372 (Publication Type: Journal Article)
• Copyright: © Journal of the Association of Physicians of India 2011.

Chemical References

• Albumins
• Biomarkers
• Glycated Hemoglobin A
• Triglycerides
• Ferritins
• Creatinine
• Iron

Topics

• Albumins
• Albuminuria (epidemiology, etiology)
• Biomarkers
• Creatinine
• Cross-Sectional Studies
• Diabetes Mellitus, Type 2 (epidemiology)
• Diabetic Nephropathies (epidemiology)
• Dyslipidemias (complications, epidemiology)
• Female
• Ferritins
• Glycated Hemoglobin (analysis)
• Glycemic Control
• Humans
• Iron
• Male
• Triglycerides